Bank of Montreal’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,770
| Closed | -$23.8K | – | 4316 |
|
|
2024
Q1 | $23.8K | Buy |
+2,770
| New | +$21.3K | ﹤0.01% | 3594 |
|
|
2022
Q3 | – | Sell |
-104
| Closed | -$2K | – | 4470 |
|
|
2022
Q2 | $2K | Sell |
104
-24
| -19% | -$601 | ﹤0.01% | 4000 |
|
|
2022
Q1 | $5K | Buy |
128
+27
| +27% | +$971 | ﹤0.01% | 4069 |
|
|
2021
Q4 | $4K | Sell |
101
-1
| -1% | -$53 | ﹤0.01% | 3432 |
|
|
2021
Q3 | $7K | Sell |
102
-67
| -40% | -$4.76K | ﹤0.01% | 3734 |
|
|
2021
Q2 | $15K | Buy |
169
+85
| +101% | +$8.08K | ﹤0.01% | 3531 |
|
|
2021
Q1 | $9K | Buy |
+84
| New | +$9.31K | ﹤0.01% | 4422 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5148 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4963 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 4870 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4804 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 5039 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 5030 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 5099 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4810 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4886 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4924 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 4905 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4373 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 4354 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 4349 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 4322 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 4222 |
|
|
2016
Q4 | – | Sell |
-50
| Closed | -$18.6K | – | 4217 |
|
|
2016
Q3 | $17K | Sell |
50
-100
| -67% | -$35K | ﹤0.01% | 3412 |
|
|
2016
Q2 | $49K | Hold |
150
| – | – | ﹤0.01% | 3065 |
|
|
2016
Q1 | $50K | Buy |
150
+100
| +200% | +$33K | ﹤0.01% | 3048 |
|
|
2015
Q4 | $23K | Buy |
+50
| New | +$31.4K | ﹤0.01% | 3344 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 4195 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 3860 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 3807 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 3789 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 3770 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 4184 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 3807 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 3515 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 3512 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 3358 |
|
Other funds holding CSCI
FDCDDQ
TWC
TRCT
Bank of Montreal's CSCI Position: Q2 2024 in Review
Bank of Montreal sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q2 2024, closing a stake of 2,770 shares — an estimated $23.8K sold.
Bank of Montreal first reported a position in CSCI in Q4 2015 and held it in 11 quarters. The position peaked at $50K in Q1 2016. 13 funds tracked by Wall St. Rank hold CSCI as of Q2 2024.
- Bank of Montreal reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Bank of Montreal sold 2,770 COSCIENS Biopharma Inc. Common Stock shares in Q2 2024, an estimated $23.8K.
- Bank of Montreal first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2015 and held it in 11 quarters.
- Bank of Montreal's COSCIENS Biopharma Inc. Common Stock position peaked at $50K in Q1 2016.
- 13 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q2 2024.
Based on Bank of Montreal's 13F filing for Q2 2024, filed 14 Aug 2024.